Login
$LKFT
$34.79 +$0.81 (2.38%) Live

Company Executives

Officer Age In this role Source
Henry Gosebruch Also a director
Chief Executive Officer
53 Not stated
Aaron Cox
Chief Financial Officer, Executive Vice President
41 Since 2025
1 year
Fred Blakeslee
General Counsel, Executive Vice President
49 Since 2025
1 year

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
9
serving now
Independent
5 of 8
stated in the proxy; 1 not stated
Average tenure
2.0 years
from year joined
CEO also chairs the board
No
Jérôme Contamine
Director Age On board Independent Committees Pay Source
Jérôme Contamine
68 2022
4 years
Independent
Nomination Committee Transaction Committee
Not stated
Henry Gosebruch
53 2025
1 year
Not stated None stated Paid as CEO
Devang Bhuva
40 2025
1 year
Not independent
Transaction Committee
Not stated
Jane Griffiths
70 2025
1 year
Independent
Audit Committee Remuneration Committee Nomination Committee · Chair Transaction Committee · Chair
Not stated
Linda Higgins
63 2019
7 years
Not independent
Remuneration Committee
Not stated
Neil Johnston
59 2025
1 year
Independent
Audit Committee · Chair
Not stated
Oleg Nodelman
48 2024
2 years
Not independent
Nomination Committee Transaction Committee
Not stated
Dawn Svoronos
72 2025
1 year
Independent
Audit Committee Remuneration Committee · Chair
Not stated
Paulo Fontoura
56 2026
this year
Independent None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Lakefront Biotherapeutics NV has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support